CompletedNot Applicable

Nebulized Hypertonic Saline Treatment in Hospitalized Children With Moderate to Severe Viral Bronchiolitis

135 participantsStarted 2008-11

Plain-language summary

The purpose of this study is planned to investigate whether frequently inhaled hypertonic saline (HS) can relieve symptoms and signs faster than normal saline (NS) and shorten length of stay (LOS) significantly for moderately to severely ill infants with bronchiolitis without apparent adverse effects.

Who can participate

Age range1 Month – 24 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * infants less than 24 months of age with first episode of wheezing. Exclusion Criteria: * age\>24 months, * previous episode of wheezing, * chronic cardiac and pulmonary disease, * immunodeficiency, * accompanying respiratory failure, * requiring mechanical ventilation, * inhaling the nebulized 3% hypertonic saline solution 12 hours before treatment, * premature infants born at less than 34 weeks gestation.

What they're measuring

To determine the efficacy of frequently nebulized HS in moderately to severely ill infants with bronchiolitis

Timeframe: 1 year

Trial details

NCT IDNCT01120496

SponsorChongqing Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2009-11

View on ClinicalTrials.gov More Bronchiolitis trials